查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1873991

生物活性伤口管理市场

Bioactive Wound Management Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格
简介目录

2024年，生物活性伤口管理市场规模约为25.2亿美元，预计到2031年将达到42.8亿美元，在此期间的复合年增长率（CAGR）为8.3%。生物活性伤口管理市场的一个显着趋势是将3D列印技术应用于伤口护理管理。

生物活性伤口管理市场分析

生物活性伤口管理市场的成长主要受慢性损伤盛行率上升和手术数量增加的推动。由于手术频率的增加，预计全球手术部位感染率将上升。而手术频率的上升主要归因于各种慢性疾病发生率的增加。根据美国国立卫生研究院 (NIH) 统计，欧洲每年约进行 2,000 万例大型手术。在杜拜，杜拜卫生局 (DHA) 报告称，2021 年杜拜共进行了约 15.9 万例手术，其中美容手术数量从 2020 年的 223,507 例翻了一番，达到 2022 年的 583,909 例。生物活性伤口管理产品有助于加速手术部位感染的癒合，预计手术数量的成长将在不久的将来推动对这些产品的需求。

生物活性伤口管理市场概览

北美目前占据生物活性伤口管理市场最大的份额，这主要归功于该地区对创新产品研发的大量投资以及众多领先製药公司的布局。北美公司受惠于其全球分销网络，能够触及世界各地的不同市场。亚太地区预计将成为成长最快的地区，其中印度、中国和澳洲等国家将引领这一成长，这主要得益于慢性伤口盛行率的上升、糖尿病和老龄化人口的增长以及医疗设施的改善。此外，该地区活跃的伤口护理管理机构也带来了丰厚的成长机会。

战略洞察

生物活性伤口管理市场的驱动因素与机会

伤口护理产品技术的进步将惠及市场

为了满足日益增长的需求，创新且经济高效的伤口癒合技术正在不断研发。伤口管理的发展历程已从基础敷料过渡到旨在维持湿润癒合环境的先进伤口护理产品。角蛋白基伤口护理产品通常与这些先进敷料搭配使用，以促进伤口上皮再生。这些产品能够被伤口吸收，进而减少换药次数，促进伤口癒合。此外，使用生物支架材料，包括完整的细胞外基质（ECM）或其成分，为改善伤口微环境、加速皮肤修復提供了新的治疗选择。

伤口护理产品领域的主要进展：

• Integra Life Sciences 提供多种伤口管理解决方案，包括 Integra 双层伤口基质、Integra 网状双层伤口基质和 Integra 流动性伤口基质。这些产品由交联牛胶原蛋白、糖胺聚醣和硅酮製成，用于治疗部分和全层伤口、压疮、静脉溃疡、糖尿病溃疡、慢性血管溃疡和手术伤口。

Matristem（ACell公司）采用天然细胞外基质支架，该支架由非交联的猪膀胱基底膜细胞外基质（UBM-ECM）组成。 UBM-ECM 的一个关键优势在于它保留了膀胱基底膜成分，该成分可将上皮组织锚定到皮肤和血管等器官的细胞外基质上。

新型伤口治疗方法的研究计画不断增加—这是一个机会

慢性伤口给外科医生带来挑战，常常导致併发症。随着慢性伤口患者数量的增加，迫切需要係统性的治疗方法，从而推动了循证护理的普及。研究和临床试验表明，生物活性伤口护理产品可以促进湿性伤口的癒合。政府机构和研究机构正积极推动伤口护理领域的进步，一些组织致力于开发创新伤口护理产品，这为预测期内的成长创造了机会。

近期发展实例：

  • 2023年7月，贝尔法斯特女王大学的研究人员开发了一种治疗糖尿病足溃疡（DFU）的新方法，该方法使用一种称为支架的3D列印绷带。这项创新技术结合了脂质奈米颗粒和水凝胶，製造出个人化的类皮肤支架，可释放大量且持续剂量的载药分子，用于治疗DFU，有望彻底改变糖尿病溃疡的治疗方式。
  • 2023年6月，伯明翰大学的研究人员推出了一项新技术，证明将银掺入「生物活性玻璃」中可以更长时间地保持其抗菌性能。与传统方法相比，这种组合能提供更有效、更持久的抗菌伤口保护。生物活性玻璃是一种独特的合成生物材料，由硅胶製成，先前曾用于骨移植。

生物活性伤口管理市场区隔分析

生物活性伤口管理市场分析的关键细分市场包括产品类型、应用和最终用户。

  • 按产品划分，市场分为生物工程皮肤替代品、胶原蛋白敷料、抗菌敷料、藻酸盐和水胶体，其中藻酸盐部分在 2023 年占据最大的市场份额。
  • 按应用领域划分，市场分为压疮、糖尿病足溃疡、静脉腿部溃疡、烧伤伤口和手术伤口，其中烧伤伤口领域在 2023 年占据市场份额领先地位。
  • 从最终用户来看，市场分为医院和诊所、门诊手术中心和其他，其中医院和诊所将在 2023 年占据市场主导地位。

生物活性伤口管理市场的地理分析

生物活性伤口管理市场报告依地域划分为五大区域：北美、亚太、欧洲、中东和非洲以及南美/中南美洲。北美一直是生物活性伤口管理市场的领先区域。由于多种因素，包括众多医疗器材製造商生产生物活性伤口管理产品，以及政府在提供先进工具和技术以实现最佳伤口护理方面的支持，预计美国市场将成为规模最大、成长最快的市场。美国企业正透过内生式和外延式策略拓展业务。例如，2021年10月，美敦力公司宣布投资7,750万美元在堪萨斯州建立新的配送中心。因此，美国对伤口敷料日益增长的需求为主要企业在伤口照护管理领域进行创新提供了重要机会。预计亚太地区未来几年将实现最高的复合年增长率。

生物活性伤口管理市场报告范围

生物活性伤口管理市场的最新发展

生物活性伤口管理市场评估是基于从一手和二手研究中收集的定性和定量资料，包括主要企业出版物、协会资料和资料库。生物活性伤口管理市场的最新发展包括：

  • 2022年7月，史密斯医疗推出了WOUND COMPASS临床支援应用程序，这是一款针对医疗保健专业人员的综合性数位化工具，旨在协助进行伤口评估和决策，以减少实践差异。 （资料来源：史密斯医疗，2022）
  • 2022年6月，美敦力公司推出了Optifoam Gentle EX泡棉敷料，该敷料旨在用于压力性损伤预防方案时减轻压力，其独特的五层结构可吸收剪切力和摩擦力，同时还能有效吸湿。 （资料来源：美敦力，2022）
  • 2022年1月，康维特收购了Triad Life Sciences Inc.，此举巩固了康维特在美国高级伤口护理领域的地位，并确保了其获得能够改善高级伤口管理和患者预后的互补创新技术。 （图片来源：康维特，2022）
  • 2021年2月，AxioBiosolutions的MaxioCel系列新一代先进伤口护理产品获得欧洲CE认证，使Axio得以进入全球快速成长的价值140亿美元的先进伤口护理市场。 （资料来源：AxioBiosolutions，2021）

生物活性伤口管理市场报告的覆盖范围和交付成果

这份题为《生物活性伤口管理市场规模及预测（2021-2031）》的报告对市场进行了全面分析，涵盖以下领域：

  • 涵盖范围内所有关键细分市场的全球、区域和国家层面的市场规模和预测
  • 市场动态，例如驱动因素、限制因素和关键机会
  • 未来主要趋势
  • 详细的PEST/波特五力模型与SWOT分析
  • 全球及区域市场分析，涵盖关键趋势、主要参与者、法规及最新发展
  • 产业格局和竞争分析，包括市场集中度、热力图分析、主要参与者和最新发展动态
  • 公司详细概况
  • 史密斯和内普

目录

第一章：引言

第二章：生物活性伤口管理市场及主要结论

第三章：研究方法

  • 覆盖范围
  • 二手研究
  • 初步研究

第四章：生物活性伤口管理市场概况

  • 概述
  • PEST分析
    • 北美洲
    • 欧洲
    • 亚太地区
    • 中东和非洲
    • 南美洲和中美洲
  • 专家意见

第五章：全球生物活性伤口管理市场及产业动态

  • 市场驱动因素
    • 伤口和溃疡发生率不断上升
    • 全球外科手术数量不断增长
    • 先进伤口护理产品的创新
  • 市场限制
    • 伤口护理管理的高昂成本
  • 市场机会
    • 加强研究力度，推出新型伤口治疗方法
  • 未来趋势
    • 3D列印在伤口护理管理的应用
  • 影响分析

第六章：生物活性伤口管理市场及全球分析

  • 全球生物活性伤口管理市场收入预测与分析
  • 全球生物活性伤口管理市场（依地域划分）－预测与分析
  • 关键参与者的市场定位

第七章：生物活性伤口管理市场及产品分类

  • 概述
  • 2024 年及 2031 年生物活性伤口管理市场占有率（依产品划分）
  • 海藻酸盐
    • 概述
    • 海藻酸盐：生物活性伤口管理市场、市场规模、收入及至2031年的预测
  • 胶原蛋白敷料
    • 概述
    • 胶原蛋白敷料：生物活性伤口管理市场、市场规模及收入预测（至2031年）
  • 抗菌敷料
    • 概述
    • 抗菌敷料：生物活性伤口管理市场、市场规模、收入及至2031年的预测
  • 生物工程皮肤替代品
    • 概述
    • 生物工程皮肤替代品：生物活性伤口管理市场、市场规模、收入及至2031年的预测
  • 水胶体
    • 概述
    • 水胶体：生物活性伤口管理市场、市场规模、收入及至2031年的预测

第八章：生物活性伤口管理市场分析与应用

  • 概述
  • 2024 年和 2031 年生物活性伤口管理市场份额（按应用领域划分）
  • 压疮
  • 糖尿病足溃疡
  • 静脉性腿部溃疡
  • 烧伤伤口
  • 手术伤口

第九章：生物活性伤口管理市场分析及最终用户细分

  • 概述
  • 2024 年和 2031 年生物活性伤口管理市场份额（按最终用户划分）
  • 医院和诊所
  • 门诊手术中心
  • 其他的

第十章：生物活性伤口管理市场及地理分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿联酋
    • 南非
  • 南美洲和中美洲
    • 巴西
    • 阿根廷

第十一章：新冠疫情对全球生物活性伤口管理市场的影响

  • 北美洲
  • 欧洲
  • 亚太
  • 世界其他地区

第十二章：生物活性伤口管理市场及产业概况

  • 概述
  • 市场中各公司采取的成长策略（%）
  • 有机发展
    • 概述
  • 无机物发展
    • 概述

第十三章：公司简介

  • Covalon Technologies Ltd.
  • ConvaTec Group Plc
  • Coloplast Group
  • Tissue Regenix Group
  • Hartman Group
  • Smith and Nephew
  • Integra Life Sciences Corporation
  • Organogenesis Inc.
  • MiMedx
  • ETS Wound Care, LLC

第十四章：附录

简介目录
Product Code: TIPMD00002256

The Bioactive Wound Management Market was valued at approximately US$ 2.52 billion in 2024 and is projected to reach US$ 4.28 billion by 2031, reflecting a CAGR of 8.3% during this period. A significant trend in the Bioactive Wound Management Market is the integration of 3D Printing in Wound Care Management.

Analysis of the Bioactive Wound Management Market

The growth of the bioactive wound management market is driven by the increasing prevalence of chronic injuries and a higher number of surgical procedures. The global rise in surgical site infections is anticipated due to the growing frequency of surgeries. This increase is largely attributed to the rising incidence of various chronic diseases. According to the National Institutes of Health (NIH), around 20 million major surgeries are performed annually in Europe. In Dubai, the Dubai Health Authority (DHA) reported approximately 159,000 surgeries in 2021, with the number of cosmetic surgeries doubling from 223,507 in 2020 to 583,909 in 2022. Bioactive wound management products facilitate quicker healing of surgical site infections, and the growing number of surgical procedures is expected to drive demand for these products in the near future.

Overview of the Bioactive Wound Management Market

North America currently holds the largest share of the bioactive wound management market, attributed to significant investments in the development of innovative products and the presence of leading pharmaceutical companies in the region. North American companies benefit from a global distribution network that allows them to reach various markets worldwide. The Asia Pacific region is anticipated to be the fastest-growing area, with countries like India, China, and Australia leading this growth due to the increasing prevalence of chronic wounds, a rising diabetic and aging population, and enhancements in healthcare facilities. Additionally, the presence of active wound care management organizations in the region presents lucrative growth opportunities.

Strategic Insights

Drivers and Opportunities in the Bioactive Wound Management Market

Advancements in Wound Care Products to Benefit the Market

Innovative and cost-effective wound-healing technologies are being developed to address the growing demand. The evolution of wound management has transitioned from basic dressings to advanced wound care products designed to maintain a moist healing environment. Keratin-based wound care products are often used alongside these advanced dressings to promote wound re-epithelialization. These products enhance healing by being absorbed into the wounds, reducing the frequency of dressing changes. Moreover, the use of biological scaffold materials, including intact extracellular matrix (ECM) or its components, offers new therapeutic options that focus on the wound microenvironment and expedite skin restoration.

Notable Advancements in Wound Care Products:

• Integra Life Sciences provides a variety of wound management solutions, including the Integra Bilayer Wound Matrix, Integra Meshed Bilayer Wound Matrix, and Integra Flowable Wound Matrix. These products, made from cross-linked bovine collagen, glycosaminoglycan, and silicone, are utilized for managing partial and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, and surgical wounds.

• Matristem (ACell Inc.) features a natural ECM scaffold composed of non-cross-linked porcine UBM-ECM. A key advantage of UBM-ECM is its retention of the urinary bladder's basement membrane component, which anchors epithelial tissues to the ECM in organs like skin and blood vessels.

Growing Research Initiatives for Novel Wound Treatments - An Opportunity

Chronic wounds pose challenges for surgeons, often leading to complications. As the number of patients with chronic wounds increases, there is a pressing need for systematic treatment approaches, driving the adoption of evidence-based care. Research and clinical trials indicate that bioactive wound care products can enhance the healing of moist wounds. Government agencies and research institutions are actively promoting advancements in wound care, with several organizations dedicated to developing innovative wound care products, creating growth opportunities in the forecast period.

Examples of Recent Developments:

  • In July 2023, researchers from Queen's University Belfast developed a novel treatment for diabetic foot ulcers (DFUs) using a 3D-printed bandage known as a scaffold. This innovative technology combines lipid nanoparticles and hydrogels to create personalized skin-like scaffolds that release both bulk and sustained doses of antibiotic-loaded molecules for DFU treatment, potentially revolutionizing diabetic ulcer care.
  • In June 2023, researchers from the University of Birmingham introduced a technique demonstrating that silver retains its antimicrobial properties longer when incorporated into 'bioactive glass'. This combination offers more effective and durable antimicrobial wound protection compared to traditional alternatives. Bioactive glasses are a unique class of synthetic biomaterials made from silicone, previously used in bone grafting.

Segmentation Analysis of the Bioactive Wound Management Market

Key segments contributing to the bioactive wound management market analysis include product type, application, and end user.

  • By product, the market is categorized into bioengineered skin substitutes, collagen-based dressings, antimicrobial dressings, alginates, and hydrocolloids, with the alginates segment holding the largest market share in 2023.
  • By application, the market is divided into pressure ulcers, diabetic foot ulcers, venous leg ulcers, burn wounds, and surgical wounds, with the burn wounds segment leading the market share in 2023.
  • In terms of end users, the market is segmented into hospitals & clinics, ambulatory surgical centers, and others, with hospitals & clinics dominating the market in 2023.

Geographical Analysis of the Bioactive Wound Management Market

The bioactive wound management market report is segmented geographically into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America. North America has been the leading region in the bioactive wound management market. The US market is expected to be the largest and fastest-growing due to several factors, including the presence of numerous medical device manufacturers producing bioactive wound management products and government support in providing advanced tools and technologies for optimal wound care. Companies in the US are expanding their presence through both organic and inorganic strategies. For example, in October 2021, Medline Industries announced a US$ 77.5 million investment to establish a new distribution center in Kansas. Thus, the growing demand for wound dressings in the US presents significant opportunities for key players to innovate in wound care management. The Asia Pacific region is projected to experience the highest CAGR in the coming years.

Scope of the Bioactive Wound Management Market Report

Recent Developments in the Bioactive Wound Management Market

The bioactive wound management market is assessed through qualitative and quantitative data collected from primary and secondary research, including key corporate publications, association data, and databases. Recent developments in the bioactive wound management market include:

  • In July 2022, Smith+Nephew launched the WOUND COMPASS Clinical Support App, a comprehensive digital tool for healthcare professionals aimed at assisting in wound assessment and decision-making to reduce practice variation. (Source: Smith+Nephew, 2022)
  • In June 2022, Medline introduced the Optifoam Gentle EX Foam Dressing, designed to alleviate pressure when used in pressure injury prevention protocols, featuring five unique layers to absorb shear force and friction while managing moisture. (Source: Medline, 2022)
  • In January 2022, Convatec acquired Triad Life Sciences Inc., enhancing Convatec's position in Advanced Wound Care in the US and securing access to complementary innovative technology that improves advanced wound management and patient outcomes. (Source: Convatec, 2022)
  • In February 2021, AxioBiosolutions received CE certification in Europe for its MaxioCel line of next-generation advanced wound care products, allowing Axio to enter the rapidly growing USD 14 billion advanced wound care market globally. (Source: AxioBiosolutions, 2021)

Coverage and Deliverables of the Bioactive Wound Management Market Report

The report titled "Bioactive Wound Management Market Size and Forecast (2021-2031)" provides a comprehensive analysis of the market, covering the following areas:

  • Market size and forecast at global, regional, and country levels for all key market segments included in the scope
  • Market dynamics such as drivers, restraints, and key opportunities
  • Key future trends
  • Detailed PEST/Porter's Five Forces and SWOT analysis
  • Global and regional market analysis covering key trends, major players, regulations, and recent developments
  • Industry landscape and competition analysis, including market concentration, heat map analysis, prominent players, and recent developments
  • Detailed company profiles
  • Smith+Nephew

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Bioactive Wound Management Marketand By Product
    • 1.3.2 Global Bioactive Wound Management Marketand By Application
    • 1.3.3 Global Bioactive Wound Management Marketand By End User
    • 1.3.4 Global Bioactive Wound Management Marketand By Geography

2. Bioactive Wound Management Marketand Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Bioactive Wound Management Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America
    • 4.2.2 Europe
    • 4.2.3 APAC
    • 4.2.4 Middle East and Africa
    • 4.2.5 South and Central America
  • 4.3 Expert Opinion

5. Global Bioactive Wound Management Marketand Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Incidences of Wounds and Ulcers
    • 5.1.2 Growing Number of Surgical Procedures Worldwide
    • 5.1.3 Innovation in Advanced Wound Care Products
  • 5.2 Market Restraints
    • 5.2.1 High Cost Associated with Wound Care Management
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Research Activities to Introduce Novel Wound Treatments
  • 5.4 Future Trends
    • 5.4.1 3D Printing in Wound Care Management
  • 5.5 Impact analysis

6. Bioactive Wound Management Marketand Global Analysis

  • 6.1 Global Bioactive Wound Management Market Revenue Forecast and Analysis
  • 6.2 Global Bioactive Wound Management Market, By Geography - Forecast and Analysis
  • 6.3 Market Positioning of Key Players

7. Bioactive Wound Management Marketand By Product

  • 7.1 Overview
  • 7.2 Bioactive Wound Management Market Share, by Product, 2024 and 2031 (%)
  • 7.3 Alginates
    • 7.3.1 Overview
    • 7.3.2 Alginates: Bioactive Wound Management Market Marketand Revenue and Forecast to 2031 (US$ million)
  • 7.4 Collagen-based Dressing
    • 7.4.1 Overview
    • 7.4.2 Collagen-based Dressing: Bioactive Wound Management Market Marketand Revenue and Forecast to 2031 (US$ million)
  • 7.5 Antimicrobial Dressings
    • 7.5.1 Overview
    • 7.5.2 Antimicrobial Dressings: Bioactive Wound Management Market Marketand Revenue and Forecast to 2031 (US$ million)
  • 7.6 Bioengineered Skin Substitutes
    • 7.6.1 Overview
    • 7.6.2 Bioengineered Skin Substitutes: Bioactive Wound Management Market Marketand Revenue and Forecast to 2031 (US$ million)
  • 7.7 Hydrocolloids
    • 7.7.1 Overview
    • 7.7.2 Hydrocolloids: Bioactive Wound Management Market Marketand Revenue and Forecast to 2031 (US$ million)

8. Bioactive Wound Management Market Analysis and By Application

  • 8.1 Overview
  • 8.2 Bioactive Wound Management Market Share, by Application, 2024 and 2031 (%)
  • 8.3 Pressure Ulcers
    • 8.3.1 Overview
    • 8.3.2 Pressure Ulcers: Bioactive Wound Management Marketand Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Diabetic Foot Ulcers
    • 8.4.1 Overview
    • 8.4.2 Diabetic Foot Ulcers: Bioactive Wound Management Marketand Revenue and Forecast to 2031 (US$ Million)
  • 8.5 Venous Leg Ulcers
    • 8.5.1 Overview
    • 8.5.2 Venous Leg Ulcers: Bioactive Wound Management Marketand Revenue and Forecast to 2031 (US$ Million)
  • 8.6 Burn Wounds
    • 8.6.1 Overview
    • 8.6.2 Burn Wounds: Bioactive Wound Management Marketand Revenue and Forecast to 2031 (US$ Million)
  • 8.7 Surgical Wounds
    • 8.7.1 Overview
    • 8.7.2 Surgical Wounds: Bioactive Wound Management Marketand Revenue and Forecast to 2031 (US$ Million)

9. Bioactive Wound Management Market Analysis and By End User

  • 9.1 Overview
  • 9.2 Bioactive Wound Management Market Share, by End User, 2024 and 2031 (%)
  • 9.3 Hospitals and Clinics
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Clinics: Bioactive Wound Management Marketand Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Ambulatory Surgical Centers
    • 9.4.1 Overview
    • 9.4.2 Ambulatory Surgical Centers: Bioactive Wound Management Marketand Revenue and Forecast to 2031 (US$ Million)
  • 9.5 Others
    • 9.5.1 Overview
    • 9.5.2 Others: Bioactive Wound Management Marketand Revenue and Forecast to 2031 (US$ Million)

10. Bioactive Wound Management Market and Geographic Analysis

  • 10.1 North America: Bioactive Wound Management Market
    • 10.1.1 Overview
    • 10.1.2 North America: Bioactive Wound Management Market - Revenue and Forecast to 2031 (USD Million)
    • 10.1.3 North America Bioactive Wound Management Market, by Product and Revenue and Forecast to 2031 (USD Million)
    • 10.1.4 North America Bioactive Wound Management Market, by Application and Revenue and Forecast to 2031 (USD Million)
    • 10.1.5 North America Bioactive Wound Management Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.1.6 North America: Bioactive Wound Management Market, by Country, 2024 and 2031 (%)
    • 10.1.7 US: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
      • 10.1.7.1 US: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
        • 10.1.7.1.1 US Bioactive Wound Management Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.1.7.1.2 US Bioactive Wound Management Market, by Application and Revenue and Forecast to 2031 (USD Million)
        • 10.1.7.1.3 US Bioactive Wound Management Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.1.8 Canada: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
      • 10.1.8.1 Canada: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
        • 10.1.8.1.1 Canada Bioactive Wound Management Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.1.8.1.2 Canada Bioactive Wound Management Market, by Application and Revenue and Forecast to 2031 (USD Million)
        • 10.1.8.1.3 Canada Bioactive Wound Management Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.1.9 Mexico: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
      • 10.1.9.1 Mexico: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
        • 10.1.9.1.1 Mexico Bioactive Wound Management Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.1.9.1.2 Mexico Bioactive Wound Management Market, by Application and Revenue and Forecast to 2031 (USD Million)
        • 10.1.9.1.3 Mexico Bioactive Wound Management Market, by End User and Revenue and Forecast to 2031 (USD Million)
  • 10.2 Europe: Bioactive Wound Management Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Bioactive Wound Management Market - Revenue and Forecast to 2031 (USD Million)
    • 10.2.3 Europe Bioactive Wound Management Market, by Product and Revenue and Forecast to 2031 (USD Million)
    • 10.2.4 Europe Bioactive Wound Management Market, by Application and Revenue and Forecast to 2031 (USD Million)
    • 10.2.5 Europe Bioactive Wound Management Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.2.6 Europe: Bioactive Wound Management Market, by Country, 2024 and 2031 (%)
    • 10.2.7 Germany: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
      • 10.2.7.1 Germany: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
        • 10.2.7.1.1 Germany Bioactive Wound Management Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.2.7.1.2 Germany Bioactive Wound Management Market, by Application and Revenue and Forecast to 2031 (USD Million)
        • 10.2.7.1.3 Germany Bioactive Wound Management Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.2.8 France: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
      • 10.2.8.1 France: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
        • 10.2.8.1.1 France Bioactive Wound Management Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.2.8.1.2 France Bioactive Wound Management Market, by Application and Revenue and Forecast to 2031 (USD Million)
        • 10.2.8.1.3 France Bioactive Wound Management Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.2.9 United Kingdom: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
      • 10.2.9.1 United Kingdom: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
        • 10.2.9.1.1 United Kingdom Bioactive Wound Management Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.2.9.1.2 United Kingdom Bioactive Wound Management Market, by Application and Revenue and Forecast to 2031 (USD Million)
        • 10.2.9.1.3 United Kingdom Bioactive Wound Management Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.2.10 Italy: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
      • 10.2.10.1 Italy: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
        • 10.2.10.1.1 Italy Bioactive Wound Management Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.2.10.1.2 Italy Bioactive Wound Management Market, by Application and Revenue and Forecast to 2031 (USD Million)
        • 10.2.10.1.3 Italy Bioactive Wound Management Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.2.11 Spain: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
      • 10.2.11.1 Spain: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
        • 10.2.11.1.1 Spain Bioactive Wound Management Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.2.11.1.2 Spain Bioactive Wound Management Market, by Application and Revenue and Forecast to 2031 (USD Million)
        • 10.2.11.1.3 Spain Bioactive Wound Management Market, by End User and Revenue and Forecast to 2031 (USD Million)
  • 10.3 Asia Pacific: Bioactive Wound Management Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Millions)
    • 10.3.3 Asia Pacific: Bioactive Wound Management Market, by Product, 2018-2031 (USD Millions)
    • 10.3.4 Asia Pacific: Bioactive Wound Management Market, by Application, 2018-2031 (USD Millions)
    • 10.3.5 Asia Pacific: Bioactive Wound Management Market, by End User, 2018-2031 (USD Millions)
    • 10.3.6 Asia Pacific: Bioactive Wound Management Market, by Country, 2024 and 2031 (%)
    • 10.3.7 China: Bioactive Wound Management Market
      • 10.3.7.1 China: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Millions)
        • 10.3.7.1.1 China: Bioactive Wound Management Market, by Product, 2018-2031 (USD Millions)
        • 10.3.7.1.2 China: Bioactive Wound Management Market, by Application, 2018-2031 (USD Millions)
        • 10.3.7.1.3 China: Bioactive Wound Management Market, by End User, 2018-2031 (USD Millions)
    • 10.3.8 Japan: Bioactive Wound Management Market
      • 10.3.8.1 Japan: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Millions)
        • 10.3.8.1.1 Japan: Bioactive Wound Management Market, by Product, 2018-2031 (USD Millions)
        • 10.3.8.1.2 Japan: Bioactive Wound Management Market, by Application, 2018-2031 (USD Millions)
        • 10.3.8.1.3 Japan: Bioactive Wound Management Market, by End User, 2018-2031 (USD Millions)
    • 10.3.9 India: Bioactive Wound Management Market
      • 10.3.9.1 India: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Millions)
        • 10.3.9.1.1 India: Bioactive Wound Management Market, by Product, 2018-2031 (USD Millions)
        • 10.3.9.1.2 India: Bioactive Wound Management Market, by Application, 2018-2031 (USD Millions)
        • 10.3.9.1.3 India: Bioactive Wound Management Market, by End User, 2018-2031 (USD Millions)
    • 10.3.10 South Korea: Bioactive Wound Management Market
      • 10.3.10.1 South Korea: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Millions)
        • 10.3.10.1.1 South Korea: Bioactive Wound Management Market, by Product, 2018-2031 (USD Millions)
        • 10.3.10.1.2 South Korea: Bioactive Wound Management Market, by Application, 2018-2031 (USD Millions)
        • 10.3.10.1.3 South Korea: Bioactive Wound Management Market, by End User, 2018-2031 (USD Millions)
    • 10.3.11 Australia: Bioactive Wound Management Market
      • 10.3.11.1 Australia: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Millions)
        • 10.3.11.1.1 Australia: Bioactive Wound Management Market, by Product, 2018-2031 (USD Millions)
        • 10.3.11.1.2 Australia: Bioactive Wound Management Market, by Application, 2018-2031 (USD Millions)
        • 10.3.11.1.3 Australia: Bioactive Wound Management Market, by End User, 2018-2031 (USD Millions)
  • 10.4 Middle East and Africa: Bioactive Wound Management Market
    • 10.4.1 Overview
    • 10.4.2 Middle East and Africa: Bioactive Wound Management Market- Revenue and Forecast to 2031 (USD Million)
    • 10.4.3 Middle East and Africa Bioactive Wound Management Market, by Product and Revenue and Forecast to 2031 (USD Million)
    • 10.4.4 Middle East and Africa Bioactive Wound Management Market, by Application and Revenue and Forecast to 2031 (USD Million)
    • 10.4.5 Middle East and Africa Bioactive Wound Management Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.4.6 Middle East and Africa: Bioactive Wound Management Market, by Country, 2024 and 2031 (%)
    • 10.4.7 Saudi Arabia: Bioactive Wound Management Marketand Revenue and Forecast to 2031 (USD Million)
      • 10.4.7.1 Saudi Arabia: Bioactive Wound Management Marketand Revenue and Forecast to 2031 (USD Million)
        • 10.4.7.1.1 Saudi Arabia Bioactive Wound Management Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.4.7.1.2 Saudi Arabia Bioactive Wound Management Market, by Application and Revenue and Forecast to 2031 (USD Million)
        • 10.4.7.1.3 Saudi Arabia Bioactive Wound Management Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.4.8 UAE: Bioactive Wound Management Marketand Revenue and Forecast to 2031 (USD Million)
      • 10.4.8.1 UAE: Bioactive Wound Management Marketand Revenue and Forecast to 2031 (USD Million)
        • 10.4.8.1.1 UAE Bioactive Wound Management Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.4.8.1.2 UAE Bioactive Wound Management Market, by Application and Revenue and Forecast to 2031 (USD Million)
        • 10.4.8.1.3 UAE Bioactive Wound Management Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.4.9 South Africa: Bioactive Wound Management Marketand Revenue and Forecast to 2031 (USD Million)
      • 10.4.9.1 South Africa: Bioactive Wound Management Marketand Revenue and Forecast to 2031 (USD Million)
        • 10.4.9.1.1 South Africa Bioactive Wound Management Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.4.9.1.2 South Africa Bioactive Wound Management Market, by Application and Revenue and Forecast to 2031 (USD Million)
      • 10.4.9.2 South Africa Bioactive Wound Management Market, by End User and Revenue and Forecast to 2031 (USD Million)
  • 10.6 South and Central America: Bioactive Wound Management Market
    • 10.6.1 Overview
    • 10.6.2 South and Central America: Bioactive Wound Management Market - Revenue and Forecast to 2031 (USD Million)
    • 10.6.3 South and Central America Bioactive Wound Management Market, by Product and Revenue and Forecast to 2031 (USD Million)
    • 10.6.4 South and Central America Bioactive Wound Management Market, by Application and Revenue and Forecast to 2031 (USD Million)
    • 10.6.5 South and Central America Bioactive Wound Management Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.6.6 South and Central America: Bioactive Wound Management Market, by Country, 2024 and 2031 (%)
    • 10.6.7 Brazil: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
      • 10.6.7.1 Brazil: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
        • 10.6.7.1.1 Brazil Bioactive Wound Management Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.6.7.1.2 Brazil Bioactive Wound Management Market, by Application and Revenue and Forecast to 2031 (USD Million)
        • 10.6.7.1.3 Brazil Bioactive Wound Management Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.6.8 Argentina: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
      • 10.6.8.1 Argentina: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
        • 10.6.8.1.1 Argentina Bioactive Wound Management Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.6.8.1.2 Argentina Bioactive Wound Management Market, by Application and Revenue and Forecast to 2031 (USD Million)
        • 10.6.8.1.3 Argentina Bioactive Wound Management Market, by End User and Revenue and Forecast to 2031 (USD Million)

11. Impact of COVID-19 Pandemic On Global Bioactive Wound Management Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

12. Bioactive Wound Management MarketandIndustry Landscape

  • 12.1 Overview
  • 12.1 Growth Strategies Done by the Companies in the Market, (%)
  • 12.2 Organic Developments
    • 12.2.1 Overview
  • 12.3 Inorganic Developments
    • 12.3.1 Overview

13. COMPANY PROFILES

  • 13.1 Covalon Technologies Ltd.
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 ConvaTec Group Plc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Coloplast Group
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Tissue Regenix Group
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Hartman Group
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Smith and Nephew
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Integra Life Sciences Corporation
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Organogenesis Inc.
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 MiMedx
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 ETS Wound Care, LLC
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Word Index